<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17-molecules-25-03919">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Arepalli</surname>
    <given-names>S.K.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Sim</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Jo</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Jun</surname>
    <given-names>K.-Y.</given-names>
   </name>
   <name>
    <surname>Kwon</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kang</surname>
    <given-names>J.-S.</given-names>
   </name>
   <name>
    <surname>Jung</surname>
    <given-names>J.-K.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIÎ± inhibitors</article-title>
  <source>Bioorg. Med. Chem.</source>
  <year>2018</year>
  <volume>26</volume>
  <fpage>5181</fpage>
  <lpage>5193</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bmc.2018.09.019</pub-id>
  <?supplied-pmid 30253887?>
  <pub-id pub-id-type="pmid">30253887</pub-id>
 </element-citation>
</ref>
